Suppr超能文献

用于治疗盂肱关节炎的肱骨头半关节置换术联合生物学方法的关节盂表面重建。手术技术。

Humeral hemiarthroplasty with biologic resurfacing of the glenoid for glenohumeral arthritis. Surgical technique.

作者信息

Krishnan Sumant G, Reineck John R, Nowinski Robert J, Harrison Donnis, Burkhead Wayne Z

机构信息

Shoulder and Elbow Service, The Carrell Clinic, 9301 North Central Expressway, Suite 400, Dallas, TX 75231, USA.

出版信息

J Bone Joint Surg Am. 2008 Mar;90 Suppl 2 Pt 1:9-19. doi: 10.2106/JBJS.G.01220.

Abstract

BACKGROUND

Biologic glenoid resurfacing was developed in 1988 as an alternative to total shoulder arthroplasty in selected (usually younger) patients with primary, posttraumatic, or postreconstructive glenohumeral arthritis. A variety of biologic surfaces, including anterior capsule, autogenous fascia lata, and Achilles tendon allograft, have been combined with a humeral hemiarthroplasty.

METHODS

From November 1988 to November 2003, thirty-four patients (thirty-six shoulders) who were managed with biologic glenoid resurfacing and humeral head replacement either with cement (ten shoulders) or without cement (twenty-six shoulders) were followed prospectively. The study group included thirty men and four women with an average age of fifty-one years. The diagnoses included primary glenohumeral osteoarthritis (eighteen shoulders), postreconstructive arthritis (twelve), posttraumatic arthritis (five), and osteonecrosis (one). Anterior capsule was used for seven shoulders, autogenous fascia lata for eleven, and Achilles tendon allograft for eighteen. All shoulders were assessed clinically and with serial radiographs.

RESULTS

The mean American Shoulder and Elbow Surgeons score was 39 points preoperatively and 91 points at the time of the most recent follow-up. According to Neer's criteria, the result was excellent for eighteen shoulders, satisfactory for thirteen, and unsatisfactory for five. Glenoid erosion averaged 7.2 mm and appeared to stabilize at five years. There were no revisions for humeral component loosening. Complications included infection (two patients), instability (three patients), brachial plexitis (one patient), and deep-vein thrombosis (one patient). Factors that appeared to be associated with unsatisfactory results were the use of capsular tissue as the resurfacing material and infection.

CONCLUSIONS

Biologic resurfacing of the glenoid can provide pain relief similar to total shoulder arthroplasty. It allows selected younger patients to maintain an active lifestyle, including weight-lifting and manual work, without the risk of polyethylene wear. On the basis of this and previous reviews, we currently recommend Achilles tendon allograft as the preferred resurfacing material when this option is chosen.

摘要

背景

生物性关节盂表面重建技术于1988年问世,作为全肩关节置换术的替代方法,用于特定(通常较年轻)的原发性、创伤后或重建后盂肱关节炎患者。多种生物性表面,包括前关节囊、自体阔筋膜和跟腱同种异体移植,已与肱骨半关节置换术联合应用。

方法

1988年11月至2003年11月,对34例(36个肩关节)接受生物性关节盂表面重建及肱骨头置换的患者进行前瞻性随访,其中10个肩关节使用骨水泥固定肱骨头,26个肩关节未使用骨水泥。研究组包括30名男性和4名女性,平均年龄51岁。诊断包括原发性盂肱骨关节炎(18个肩关节)、重建后关节炎(12个)、创伤后关节炎(5个)和骨坏死(1个)。7个肩关节使用前关节囊,11个使用自体阔筋膜,18个使用跟腱同种异体移植。所有肩关节均进行临床评估及系列X线片检查。

结果

美国肩肘外科医师协会(ASES)评分术前平均为39分,最近一次随访时为91分。根据Neer标准,18个肩关节结果为优,13个为良,5个为差。关节盂侵蚀平均7.2mm,且在5年时似乎趋于稳定。未因肱骨假体松动而进行翻修。并发症包括感染(2例患者)、不稳定(3例患者)、臂丛神经炎(1例患者)和深静脉血栓形成(1例患者)。与不满意结果相关的因素是使用关节囊组织作为表面重建材料和感染。

结论

关节盂的生物性表面重建可提供与全肩关节置换术相似的疼痛缓解。它使特定的年轻患者能够保持积极的生活方式,包括举重和体力劳动,而无聚乙烯磨损风险。基于本研究及既往综述,当选择该方法时,我们目前推荐跟腱同种异体移植作为首选的表面重建材料。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验